hLF1-11 + hLF1-11 + Placebo
Phase 1/2Withdrawn 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Candidaemia
Conditions
Candidaemia
Trial Timeline
Jul 1, 2008 → Jan 1, 2009
NCT ID
NCT00509834About hLF1-11 + hLF1-11 + Placebo
hLF1-11 + hLF1-11 + Placebo is a phase 1/2 stage product being developed by AM-Pharma for Candidaemia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00509834. Target conditions include Candidaemia.
Hype Score Breakdown
Clinical
13
Activity
8
Company
2
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00509834 | Phase 1/2 | Withdrawn |